SCHEMBL2829096

SCHEMBL2829096

COc1ccccc1C(=O)C=CN1CCC(N2CCCCC2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
NPC1 O15118 3/20 0.51
MAPT P10636 3/20 0.51
LMNA P02545 2/20 0.51
MAPK1 P28482 2/20 0.51
USP2 O75604 1/20 0.51
KDM4E B2RXH2 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
L3MBTL3 Q96JM7 2/20 0.48
ABCG2 Q9UNQ0 1/20 0.48
TP53BP1 Q12888 1/20 0.48
RAB9A P51151 2/20 0.48
HTT P42858 2/20 0.48
TP53 P04637 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
AHR P35869 1/20 0.47
GFER P55789 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2831500 0.90 KDM4E (0.50) ALDH1A1NPC1MAPTLMNAMAPK1
SCHEMBL2829559 0.85 KDM2B (0.55) ALDH1A1NPC1MAPTLMNAMAPK1
SCHEMBL4380856 0.82 GAA (0.52) ALDH1A1NPC1MAPTLMNAMAPK1
SCHEMBL2833138 0.81 ALDH1A1 (0.46) ALDH1A1NPC1MAPTLMNAMAPK1
SCHEMBL4382981 0.81 GAA (0.53) ALDH1A1NPC1MAPTLMNAMAPK1
SCHEMBL2833287 0.80 GAA (0.52) ALDH1A1LMNAKDM4ESMN1; SMN2L3MBTL1
SCHEMBL2829775 0.78 ALDH1A1 (0.54) ALDH1A1NPC1MAPTLMNAMAPK1
SCHEMBL2829562 0.78 GAA (0.53) ALDH1A1MAPTLMNAMAPK1KDM4E
SCHEMBL4378208 0.77 KDM2B (0.54) ALDH1A1NPC1MAPTLMNAMAPK1
SCHEMBL4026644 0.77 ABCG2 (0.49) ALDH1A1NPC1MAPTLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP claimed
EP-2243776-A1 Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor High Point Pharmaceuticals, LLC (US) 2010-10-27 EP disclosed
US-7064135-B2 Substituted piperidines NOVO NORDISK INC. (DK) 2006-06-20 US disclosed